Pet Financial News
Imbria Reports Positive Topline Results for Investigational New Drug Ninerafaxstat in Sufferers with Cardiac Ischemia and Power Stable Angina
– The IMPROVE-ISCHEMIA Phase 2 medical trial met the first endpoint of tolerability and security; 8-weeks therapy with ninerafaxstat additionally demonstrated a statistically important enchancment...
Pet Financial News
Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer’s Disease From Additional...
Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV76% Of Patients Showed No Decline...
Pet Financial News
New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Exhibits Promise for Potential New Era of Treatments in Early Alzheimer’s Disease
In the Phase 1b examine, favorable tendencies have been reported for the high-dose teams on a number of measures of cognition and performance.First examine...
- Advertisement -
Pet Financial News
Molecure Files an Investigational New Drug (IND) application for lead scientific prospect OATD-01 with U.S. FDA ahead of a prepared Phase 2 lung sarcoidosis...
OATD-01 is an initially in class chitotriosidase 1 (CHIT1) inhibitor with illness customizing capacity in sarcoidosis and other interstitial lung illnessClearance of the...
Pet Financial News
Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational FAMILY PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer
− Results at the American Urological Association’s 2023 Annual Meeting (AUA2023) –MONROE AREA, N.J. & OXFORD, England, April 29, 2023--(BUSINESS WIRE)--Blue Earth Diagnostics,...
Pet Financial News
Blue Earth Diagnostics Announces Data-sharing Arrangement with Siemens Healthineers and the University Health Center of Technical University of Munich (TUM) for 18F-rhPSMA-7.3, an Investigational...
MONROE AREA, N.J. & & OXFORD, England, October 18, 2022--( SERVICE WIRE)-- Blue Earth Diagnostics, a Bracco business and acknowledged leader in...
- Advertisement -
Pet Financial News
MesaGreen Pharmaceutical Business Files an Investigational New Animal Drug Application
The application covers the advancement of the business's K9MGP item which, when authorized, will efficiently manage an active seizure in pets that...
-Advertisement-
Must read
-Advertisement-
